 NEW YORK, Sept. 1, 2021 PRNewswire -- Chardan Healthcare Acquisition 2 Corp. NYSE: CHAQ CHAQ, a special purpose acquisition company sponsored by Chardan Capital Markets Chardan, today announced the results for the proposals considered and voted upon by its stockholders at its special meeting held on September 1, 2021 the Special Meeting, regarding the proposed business combination with Renovacor, Inc. Renovacor, an earlystage biotechnology company developing adeno-associated virus AAVbased gene therapies for devastating cardiovascular and central nervous system diseases resulting from BAG3 gene variants. 